ICD-10-PCS Billable Code

0G5L3ZZ

Destruction Superior Parathyroid Gland, Right to No Qualifier with No Device, Percutaneous Approach

Procedural Specifications

Clinical Axis Detail Definition
Section0 Medical and Surgical
Body SystemG Endocrine System
Operation5 Destruction
Body PartL Superior Parathyroid Gland, Right
Approach3 Percutaneous
DeviceZ No Device
QualifierZ No Qualifier

Operation Definition

Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

Procedure Overview

Destruction procedures in the endocrine system eliminate abnormal or diseased tissue in a gland, such as a thyroid nodule, adrenal mass, or pituitary lesion, using energy sources like radiofrequency, laser, cryotherapy, or chemical agents rather than by cutting the tissue out. The gland or the surrounding tissue is not physically removed from the body; it is destroyed in place and the body absorbs or walls off the treated area over time.

This approach is often chosen for patients who are not good candidates for surgical removal, for smaller lesions that do not require full excision, or when preserving as much of the surrounding healthy gland tissue as possible is a priority, such as with certain benign thyroid nodules treated by ablation.

Anatomy & Axis Detail

Superior Parathyroid Gland, Right

The right superior parathyroid gland is one of typically four small parathyroid glands, situated on the posterior aspect of the right thyroid lobe, that secretes parathyroid hormone to regulate serum calcium. Destruction in place is an atypical approach for parathyroid disease, since primary hyperparathyroidism from a single adenoma is more commonly managed surgically, but ablative techniques such as ultrasound-guided ethanol or radiofrequency treatment may be used when a hyperfunctioning right superior gland is targeted nonoperatively, for instance in a patient with significant surgical risk or persistent disease after prior neck surgery. Its consistent location near the posterior capsule of the right thyroid lobe and close relationship to the recurrent laryngeal nerve requires precise imaging to confirm gland identity and avoid nerve injury. Documentation must specify the superior right gland, since parathyroid tissue can be ectopic and easily conflated with the inferior gland or with thyroid nodules.

Approach: Percutaneous

Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.

Coding & Documentation

The operative note should describe an energy-based or chemical method used to eradicate tissue in place, with no portion of the gland physically excised or taken out. Coders need to identify the exact energy source and gland involved, since the approach and device values depend on whether an image-guided percutaneous probe, an endoscopic device, or an open technique was used.

The most frequent error is coding Destruction when any portion of tissue was actually cut out and removed for pathology, which instead falls under Excision or Resection. When a biopsy is taken from the same lesion before it is ablated, that sampling should be coded separately as an Excision.

Commonly Confused With

ExcisionExcision and Resection are the closest relatives, distinguished by whether tissue is physically taken out of the body rather than destroyed in place.
FragmentationDestruction is also sometimes confused with Fragmentation, which breaks solid material into pieces without necessarily eradicating it, a distinction more relevant to calculi than to soft endocrine tissue.